Miller Investment Management LP lifted its holdings in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 13.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 207,535 shares of the company’s stock after purchasing an additional 24,446 shares during the period. VanEck Pharmaceutical ETF comprises approximately 2.1% of Miller Investment Management LP’s holdings, making the stock its 10th biggest holding. Miller Investment Management LP’s holdings in VanEck Pharmaceutical ETF were worth $19,722,000 as of its most recent SEC filing.
Other institutional investors have also recently modified their holdings of the company. Optimum Investment Advisors purchased a new stake in VanEck Pharmaceutical ETF in the 2nd quarter worth approximately $27,000. GPS Wealth Strategies Group LLC purchased a new position in shares of VanEck Pharmaceutical ETF during the 2nd quarter worth about $42,000. CWM LLC acquired a new stake in shares of VanEck Pharmaceutical ETF in the second quarter worth approximately $55,000. International Assets Investment Management LLC purchased a new stake in VanEck Pharmaceutical ETF in the second quarter valued at approximately $86,000. Finally, Comerica Bank increased its position in VanEck Pharmaceutical ETF by 39.4% during the first quarter. Comerica Bank now owns 1,337 shares of the company’s stock worth $121,000 after purchasing an additional 378 shares during the last quarter.
VanEck Pharmaceutical ETF Stock Up 0.3 %
NASDAQ:PPH opened at $90.48 on Wednesday. VanEck Pharmaceutical ETF has a fifty-two week low of $77.70 and a fifty-two week high of $99.51. The firm’s 50 day moving average is $91.72 and its two-hundred day moving average is $93.04. The company has a market cap of $668.65 million, a P/E ratio of 21.04 and a beta of 0.72.
About VanEck Pharmaceutical ETF
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Read More
- Five stocks we like better than VanEck Pharmaceutical ETF
- What is the Dogs of the Dow Strategy? Overview and Examples
- 3 Small-Cap Stocks on the Rise With Over 4% Dividend Yields
- Health Care Stocks Explained: Why You Might Want to Invest
- Insiders Keep Buying These Stocks: 2 to Buy, 1 to Avoid
- What Does Downgrade Mean in Investing?
- Triumph Financial Stock Breakout: Why It’s Just the Beginning
Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report).
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.
